Skip to main content

Table 2 HLA-A antigen frequency among individuals with ESRD and healthy controls

From: Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study

 

Patients N = 141

Control N = 190

   

Antigens

Count

Antigen frequency

Count

Antigen frequency

Odds ratio

95 % confidence interval (95 % CI)

P value

A1

4

2.8 %

1

0.5 %

5.52

0.610–49.920

NS

A2

61

43.3 %

96

50.5 %

0.75

0.482–1.157

NS

A3

2

1.4 %

  

6.83

0.325–143.350

NS

A24

48

34.0 %

59

31.1 %

1.15

0.720–1.824

NS

A11

86

61.0 %

112

58.9 %

1.09

0.698–1.699

NS

A26

5

3.5 %

10

5.3 %

0.66

0.221–1.981

NS

A29

1

0.0 %

1

0.5 %

1.35

0.084–21.771

NS

A30

7

5.0 %

3

1.6 %

3.26

0.827–12.822

NS

A31

3

2.1 %

9

4.7 %

0.44

0.116–1.645

NS

A32

  

2

1.1 %

0.27

0.013–5.593

NS

A33

32

22.7 %

37

19.5 %

1.21

0.712–2.069

NS

A34

3

2.1 %

  

9.63

0.493–187.918

NS

A68

  

1

0.5 %

0.45

0.018–11.040

NS

  1. N number, NS not significant
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us